These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35830835)
1. Serum neurofilament light levels are predictive of all-cause mortality in late middle-aged individuals. Nguyen AD; Malmstrom TK; Aggarwal G; Miller DK; Vellas B; Morley JE EBioMedicine; 2022 Aug; 82():104146. PubMed ID: 35830835 [TBL] [Abstract][Full Text] [Related]
2. Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population-an analysis from the MEMO study. Rübsamen N; Maceski A; Leppert D; Benkert P; Kuhle J; Wiendl H; Peters A; Karch A; Berger K BMC Med; 2021 Feb; 19(1):38. PubMed ID: 33583409 [TBL] [Abstract][Full Text] [Related]
3. Serum total tau, neurofilament light, and glial fibrillary acidic protein are associated with mortality in a population study. Halloway S; Evans DA; Desai P; Dhana K; Beck T; Rajan KB J Am Geriatr Soc; 2024 Jan; 72(1):149-159. PubMed ID: 37818793 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study. Carmona-Iragui M; Alcolea D; Barroeta I; Videla L; Muñoz L; Van Pelt KL; Schmitt FA; Lightner DD; Koehl LM; Jicha G; Sacco S; Mircher C; Pape SE; Hithersay R; Clare ICH; Holland AJ; Nübling G; Levin J; Zaman SH; Strydom A; Rebillat AS; Head E; Blesa R; Lleó A; Fortea J Lancet Neurol; 2021 Aug; 20(8):605-614. PubMed ID: 34302785 [TBL] [Abstract][Full Text] [Related]
5. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study. van der Ende EL; Meeter LH; Poos JM; Panman JL; Jiskoot LC; Dopper EGP; Papma JM; de Jong FJ; Verberk IMW; Teunissen C; Rizopoulos D; Heller C; Convery RS; Moore KM; Bocchetta M; Neason M; Cash DM; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Carmela Tartaglia M; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; de Mendonça A; Santana I; Butler C; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Frisoni GB; Cappa S; Pijnenburg YAL; Rohrer JD; van Swieten JC; Lancet Neurol; 2019 Dec; 18(12):1103-1111. PubMed ID: 31701893 [TBL] [Abstract][Full Text] [Related]
6. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3. Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998 [TBL] [Abstract][Full Text] [Related]
7. Thirty years after anorexia nervosa onset, serum neurofilament light chain protein concentration indicates neuronal injury. Wentz E; Dobrescu SR; Dinkler L; Gillberg C; Gillberg C; Blennow K; Råstam M; Zetterberg H Eur Child Adolesc Psychiatry; 2021 Dec; 30(12):1907-1915. PubMed ID: 33040187 [TBL] [Abstract][Full Text] [Related]
8. Elevated Serum Neurofilament Light Chain Levels Are Associated With All-Cause Mortality: Evidence From National Health and Nutrition Examination Survey. Chen X; Lin Y; Wei K J Gerontol A Biol Sci Med Sci; 2023 Dec; 78(12):2382-2386. PubMed ID: 36811342 [TBL] [Abstract][Full Text] [Related]
9. Serum neurofilament light chain as a prognostic marker of all-cause mortality in a national sample of US adults. Beydoun MA; Noren Hooten N; Georgescu MF; Beydoun HA; Eid SM; Fanelli-Kuczmarski MT; Evans MK; Zonderman AB Eur J Epidemiol; 2024 Jul; 39(7):795-809. PubMed ID: 38771439 [TBL] [Abstract][Full Text] [Related]
10. Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis. Brenner J; Mariotto S; Bastiaansen AEM; Paunovic M; Ferrari S; Alberti D; de Bruijn MAAM; Crijnen YS; Schreurs MWJ; Neuteboom RF; Damoiseaux JGMC; de Vries JM; Titulaer MJ Neurology; 2023 May; 100(21):e2204-e2213. PubMed ID: 37015822 [TBL] [Abstract][Full Text] [Related]
11. Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy. Rasing I; Voigt S; Koemans EA; de Kort AM; van Harten TW; van Etten ES; van Zwet EW; Stoops E; Francois C; Kuiperij HB; Klijn CJM; Schreuder FHBM; van der Weerd L; van Osch MJP; van Walderveen MAA; Verbeek MM; Terwindt GM; Wermer MJH Alzheimers Res Ther; 2024 Apr; 16(1):86. PubMed ID: 38654326 [TBL] [Abstract][Full Text] [Related]
12. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study. de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776 [TBL] [Abstract][Full Text] [Related]
13. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis. Lu CH; Macdonald-Wallis C; Gray E; Pearce N; Petzold A; Norgren N; Giovannoni G; Fratta P; Sidle K; Fish M; Orrell R; Howard R; Talbot K; Greensmith L; Kuhle J; Turner MR; Malaspina A Neurology; 2015 Jun; 84(22):2247-57. PubMed ID: 25934855 [TBL] [Abstract][Full Text] [Related]
14. Serum neurofilament light chain level as a predictor of cognitive stage transition. Lee EH; Kwon HS; Koh SH; Choi SH; Jin JH; Jeong JH; Jang JW; Park KW; Kim EJ; Kim HJ; Hong JY; Yoon SJ; Yoon B; Kang JH; Lee JM; Park HH; Ha J Alzheimers Res Ther; 2022 Jan; 14(1):6. PubMed ID: 34996525 [TBL] [Abstract][Full Text] [Related]
15. Examination of Neurofilament Light Chain Serum Concentrations, Physical Activity, and Cognitive Decline in Older Adults. Desai P; Dhana K; DeCarli C; Wilson RS; McAninch EA; Evans DA; Rajan KB JAMA Netw Open; 2022 Mar; 5(3):e223596. PubMed ID: 35315915 [TBL] [Abstract][Full Text] [Related]
16. Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndrome. van Tilburg SJ; Teunissen CE; Maas CCHM; Thomma RCM; Walgaard C; Heijst H; Huizinga R; van Doorn PA; Jacobs BC EBioMedicine; 2024 Apr; 102():105072. PubMed ID: 38518653 [TBL] [Abstract][Full Text] [Related]
17. Development of an age-adjusted model for blood neurofilament light chain. Harp C; Thanei GA; Jia X; Kuhle J; Leppert D; Schaedelin S; Benkert P; von Büdingen HC; Hendricks R; Herman A Ann Clin Transl Neurol; 2022 Apr; 9(4):444-453. PubMed ID: 35229997 [TBL] [Abstract][Full Text] [Related]
18. Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study. Verberk IMW; Laarhuis MB; van den Bosch KA; Ebenau JL; van Leeuwenstijn M; Prins ND; Scheltens P; Teunissen CE; van der Flier WM Lancet Healthy Longev; 2021 Feb; 2(2):e87-e95. PubMed ID: 36098162 [TBL] [Abstract][Full Text] [Related]
19. Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study. Quiroz YT; Zetterberg H; Reiman EM; Chen Y; Su Y; Fox-Fuller JT; Garcia G; Villegas A; Sepulveda-Falla D; Villada M; Arboleda-Velasquez JF; Guzmán-Vélez E; Vila-Castelar C; Gordon BA; Schultz SA; Protas HD; Ghisays V; Giraldo M; Tirado V; Baena A; Munoz C; Rios-Romenets S; Tariot PN; Blennow K; Lopera F Lancet Neurol; 2020 Jun; 19(6):513-521. PubMed ID: 32470423 [TBL] [Abstract][Full Text] [Related]